Isolation, purification and biological activity of major docetaxel metabolites from human feces.

Alexander Sparreboom(Slotervaartziekenhuis), Jos H. Beijnen(The Netherlands Cancer Institute), E J Scherrenburg, Olaf van Tellingen(Dutch Cancer Society), Manon Huizing(The Netherlands Cancer Institute), Cees Versluis, W J Nooijen, Jan J. B. Boesen
Drug Metabolism and Disposition
June 1, 1996
10.1016/s0090-9556(25)07385-4
Cited by 68

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688